Trial intelligence / Profile preview

Ciprofol vs propofol and postoperative recovery quality

ChiCTR2400085402Phase 4Not yet recruiting

Sponsor
Peking University People's Hospital
Start
Jun 2024
Modality
Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial in postoperative pain, postoperative delirium (POD) and postoperative nausea and vomiting (PONV) comparing ciprofol group with propofol group (2 arms). Primary endpoints: Awakening Restlessness score (RS) and Bispectral index (BIS). Planned start Jun 2024; status: not yet recruiting.

02

Drugs

ciprofolpropofol
03

Conditions

postoperative painpostoperative delirium (POD)postoperative nausea and vomiting (PONV)

Beyond the preview

Go deeper on ChiCTR2400085402.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2400085402.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call